Girard Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,751
Closed -$229K 69
2017
Q3
$229K Sell
1,751
-1,358
-44% -$180K 0.2% 112
2017
Q2
$410K Buy
3,109
+462
+17% +$58.9K 0.31% 81
2017
Q1
$330K Sell
2,647
-3,371
-56% -$403K 0.28% 96
2016
Q4
$693K Sell
6,018
-591
-9% -$68.3K 0.6% 45
2016
Q3
$781K Buy
6,609
+784
+13% +$95.1K 0.8% 31
2016
Q2
$701K Sell
5,825
-937
-14% -$106K 0.64% 40
2016
Q1
$735K Sell
6,762
-41
-0.6% -$4.25K 0.72% 36
2015
Q4
$701K Buy
+6,803
New +$684K 0.7% 36

Other funds holding JNJ

Girard Securities's JNJ Position: Q4 2017 in Review

Girard Securities sold out of Johnson & Johnson (JNJ) in Q4 2017, closing a stake of 1,751 shares — an estimated $229K sold.

Girard Securities first reported a position in JNJ in Q4 2015 and held it in 8 quarters. The position peaked at $781K in Q3 2016. 2,623 funds tracked by Wall St. Rank hold JNJ as of Q4 2017.

  • Girard Securities reported no remaining Johnson & Johnson position as of Q4 2017 after selling out during the quarter.
  • Girard Securities sold 1,751 Johnson & Johnson shares in Q4 2017, an estimated $229K.
  • Girard Securities first reported a position in Johnson & Johnson in Q4 2015 and held it in 8 quarters.
  • Girard Securities's Johnson & Johnson position peaked at $781K in Q3 2016.
  • 2,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2017.

Based on Girard Securities's 13F filing for Q4 2017.